Business Update Positive

2026-05-22 18:29

Management reported strong FY26 performance, surpassing targets, and guided for 30-35% revenue CAGR and 3-4% margin improvement over the next three years. Long-term, they target INR 3,000 crore revenue and INR 500 crore PAT by 2030. The 10,000 MT R-32 Bhilwara facility is expected to start production by October 2026, projecting FY27 turnover of INR 1100-1200 crore and PAT of INR 180 crore. The Mumbattu facility, expanding specialty gas capabilities, will be operational by August 2026. Capex for the HFO plant is estimated at INR 400 crore, with no further equity dilution planned. Robust demand is anticipated from refrigerant and semiconductor industries.

Business Update Neutral

2026-05-19 10:47

Stallion India Fluorochemicals Ltd. announced the audio recording of its Earnings Conference Call, held on May 18, 2026, is now available. The call discussed the Audited Financial Results for the quarter and financial year ended March 31, 2026, and the recording can be accessed via a Google Drive link.

Financials Positive

2026-05-14 15:15

Stallion India Fluorochemicals reported FY26 Total Revenue of ₹434.12 Cr vs ₹379.47 Cr (▲14.40% YoY), EBITDA ₹61.35 Cr vs ₹49.74 Cr (▲23.34% YoY), PAT ₹43.84 Cr vs ₹32.33 Cr (▲35.61% YoY). EBITDA Margin was 14.13% vs 13.11% (▲102bps). Management guided for a revenue CAGR of 30-35% over the next 3 years with 3-4% margin improvement. The proposed 10,000 MT R-32 manufacturing facility at Bhilwara is on track for commencement by October 2026.

Financials Negative

2026-05-13 13:36

Stallion India Fluorochemicals Limited reported Q4 FY26 Revenue of ₹109.99 Cr vs ₹151.57 Cr (▼27.42% YoY), EBITDA of ₹16.35 Cr vs ₹18.72 Cr (▼12.66% YoY), and PAT of ₹10.93 Cr vs ₹13.27 Cr (▼17.63% YoY). EBITDA Margin was 14.86% vs 12.35% (▲251bps). The Board also approved the appointment of Ms. Swati Ghosh as an Independent Director for a 5-year term.

Business Update Neutral

2026-05-12 16:53

Stallion India Fluorochemicals Ltd. announced an Earnings Conference Call to discuss the financial results for Q4 & FY ended March 31, 2026. The conference call is scheduled for Monday, May 18, 2026, at 04:00 P.M. IST, with Mr. Shazad Rustomji, Managing Director & CEO, as a speaker.

Governance Neutral

2026-04-30 22:43

Stallion India Fluorochemicals Ltd. issued a Postal Ballot Notice dated April 30, 2026, seeking members' approval through remote e-voting for a Special Resolution to vary the terms of objects of its Initial Public Offering (IPO) proceeds. The remote e-voting period will commence on May 01, 2026, and conclude on May 30, 2026. Members as of the April 24, 2026 cut-off date are eligible to vote. The results will be announced on or before June 06, 2026.

Business Update Positive

2026-04-23 19:41

Stallion India Fluorochemicals Ltd. clarified share price movement, stating it's market-driven and citing previously disclosed positive business updates like industrial plot allotment, environmental clearance for a new plant, an MoU with Rajasthan for a manufacturing plant, and a strategic partnership for Liquid Helium sourcing.

Routine Neutral

2026-04-23 19:11

New Filing detected. See link for details.

Routine Neutral

2026-04-22 10:49

New Filing detected. See link for details.

Routine Neutral

2026-04-22 10:37

New Filing detected. See link for details.

Governance Negative

2026-04-21 18:11

CRITICAL RED FLAG DETECTED

Shri Gautam Lath, Independent Director of Stallion India Fluorochemicals Ltd., resigned on April 20, 2026, citing 'increasing professional commitments'. He also stepped down from all committees.

Governance Neutral

2026-04-21 12:31

Stallion India Fluorochemicals Ltd. announced the appointment of M/s. Himani R. Patel & Associates, Chartered Accountants, as the Internal Auditor for the Financial Year 2026-27. The appointment was approved by the Board on 20th April, 2026.

Governance Negative

2026-04-20 12:57

CRITICAL RED FLAG DETECTED

At its April 20, 2026 meeting, the Board noted the resignation of Mr. Gautam Lath, an Independent Director. It also approved varying the utilization of IPO proceeds, subject to shareholder approval via postal ballot, with April 24, 2026, as the cut-off date.

Business Update Neutral

2026-04-18 18:47

Stallion India Fluorochemicals Ltd. announced virtual group Analyst/Investor Meets on April 23, 2026, with firms like Philip PCG, Ashika stock broking, and Ventura Securities. The company clarified that no unpublished price sensitive information will be discussed during these meetings.

Routine Neutral

2026-04-13 20:51

New Filing detected. See link for details.

Routine Neutral

2026-04-11 11:43

Stallion India Fluorochemicals Ltd. submitted a certificate under SEBI Regulation 74(5) for the quarter ended March 31, 2026, confirming that all shares are in demat form and no rematerialisation requests were received.

Routine Neutral

2026-04-01 23:12

The trading window for designated persons and their relatives is closed from April 01, 2026, until 48 hours after the declaration of audited financial results for the quarter and financial year ended March 31, 2026, as per SEBI PIT Regulations.

Ownership Positive

2026-03-02 20:09

The company announced a revised outcome correcting the face value of rights issue equity shares from Re. 1 to Rs. 10. It confirms allotment of 3,67,60,483 shares at Rs. 99 each, raising the paid-up capital to Rs. 1,16,08,57,370 for 11,60,85,737 shares.

Ownership Positive

2026-03-02 19:07

Stallion India Fluorochemicals Ltd. announced the allotment of 3,67,60,483 fully paid-up equity shares at ₹99.00 each, pursuant to its Rights Issue. This increases the paid-up equity capital to 11,60,85,737 shares, successfully raising capital for the company.

Business Update Positive

2026-02-23 09:27

Stallion India Fluorochemicals Limited received land allotment approval from RIICO for its proposed ₹200 crore Hydrofluoroolefin (HFO) manufacturing plant in Rajasthan, with work planned for 2027. The project is eligible for incentives and targets 30-35% revenue CAGR over three years.

Business Update Negative

2026-02-14 22:27

CRITICAL RED FLAG DETECTED

Monitoring Agency reported material deviations in IPO fund utilization for Q3FY26 (quarter ended Dec 31, 2025). This includes ₹3.99 crore excess spending on issue expenses (25-50% deviation) without shareholder approval, delays in capex, and commingling of funds. This results in a ₹7.70 crore deficit for other IPO objects.

STALLION

Stallion India Fluorochemicals Limited

Filing History

Unlock Full History